PROFIL Institut fuer Stoffwechselforschung GmbH

Neuss 38 trials 11 recruiting

38 Registered trials

11 Currently recruiting

Organisation

PROFIL Institut fuer Stoffwechselforschung GmbH

Location

Neuss, Germany

Identifier

ORG-100016387

Address

Hellersbergstrasse 9, Hammfeld, 41460, Germany

Departments

N/A
NA
not applicable

Clinical trials at this site (38)

Search interface

A study to test how either a capsule or a tablet with NDec (Decitabine and Tetrahydrouridine) works in the body of healthy people Not authorised

2023-504582-22-00 Sickle Cell Disease 1
Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D Not authorised

2023-508054-25-00 Type 2 diabetes 3
A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants with Type 2 Diabetes Mellitus(T2DM… Pending

2025-521401-41-00 Type 2 Diabetes Mellitus (T2DM) and overweight or obesi 3
A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity Pending

2025-523873-41-00 Overweight Obesity 3
A three-part first-in-human trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of GUB-UCN2 in healthy lean and obes… Pending

2025-524921-42-00 Type 2 Diabetes 1
A study to test whether survodutide helps people living with obesity or overweight and with a confirmed or presumed liver disease called non… Recruiting

2023-505303-23-00 Obesity 5 2024-07-26
Bioavailability, Biopotency and Food effect study of SCD0503 compared to subcutaneous regular human insulin Recruiting

2024-519502-12-00 Type 1 diabetes 1 2026-05-29
A research study investigating the effect of NNC0497-0040 in healthy participants, participants with overweight or obesity, and participants… Recruiting

2025-523978-16-00 Type I diabetes 1 2026-05-04
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes Recruiting

2025-521595-55-00 Type 2 Diabetes 3 2026-03-25
A phase 1 glucose clamp trial investigating the bioequivalence of CVC-001 cartridge vs U.S.-Licensed Lantus® in healthy male volunteers Recruiting

2024-516472-15-00 Type 1 diabetes mellitus (healthy participants) 2 2026-01-06
A research study of a new medicine, NNC9733-0001, in healthy participants and participants with type 2 diabetes Recruiting

2024-519382-22-00 Healthy Participants and Participants with type 2 diabe 1 2025-11-10
A Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Degludec and Insulin … Recruiting

2025-522662-67-00 Type 2 Diabetes Mellitus 3 2025-08-13
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellit… Recruiting

2024-518470-13-00 Diabetes Mellitus 3 2025-05-30
A Study of LY4057996 in Healthy Participants and Participants with Type 1 and Type 2 Diabetes (YKAA) Recruiting

2024-519151-28-00 Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, T 1 2025-05-14
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389 Recruiting

2024-514853-31-00 Obesity / Right heart failure (healthy participants) 1 2024-09-10
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3938577 in Healthy Participants and Participants wit… Recruiting

2023-510365-10-00 Type 1 Diabetes Mellitus 3 2024-04-29
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabe… Ended

2024-519533-38-00 Diabetes mellitus type 1 3 2025-06-24
A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine… Ended

2023-504215-32-00 Overweight and obesity 9 2023-09-28
A Double-blind, Placebo-controlled, Multiple-Dose, 2-Period Crossover Study to Evaluate the Effect of Steady-state AZD6793 on the Steady-sta… Halted

2025-522551-25-00 Type 2 Diabetes Mellitus 3 2026-01-14
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinet… Halted

2024-514744-91-00 Obesity/overweight (healthy subjects) 3 2024-09-16
A research study of a new medicine NNC0363-1063 in participants with type 1 diabetes Ended

2025-521593-33-00 Diabetes type 1 3 2025-12-03
A Trial to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR33 Compared with Insulin Degludec at stea… Ended

2025-523052-32-00 Type 1 diabetes Mellitus 3 2025-10-17
Vonafexor in Impaired Renal Function and Suspected MASH Ended

2023-509192-16-00 Impaired renal function and suspected MASH 4 2025-07-01
A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump. Ended

2024-520230-29-00 Diabetes mellitus type 2 3 2025-07-01